Taofeek Owonikoko, MD, PhD
University of Maryland, Baltimore · Emory University · Emory University Winship Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Taofeek Owonikoko, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:25 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07057791 · Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung CancerPrECOG, LLC. · recruiting · Extensive Stage Lung Small Cell Cancer · study chair
- Ph2NCT05450965 · Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung CancerUniversity of Maryland, Baltimore · recruiting · Small-cell Lung Cancer, Small Cell Lung Carcinoma · principal investigator
- Ph1NCT05403723 · Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCUniversity of Maryland, Baltimore · suspended · Extensive-stage Small-cell Lung Cancer · principal investigator
- Ph2NCT02701400 · Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung CancerEmory University · completed · Recurrent Small Cell Lung Carcinoma · principal investigator
- Ph1NCT01470209 · A Phase I Study of BKM120 and Everolimus in Advanced Solid MalignanciesEmory University · completed · Solid Tumors, Lung Cancer · principal investigator
- Ph2NCT01470248 · Study of Arsenic Trioxide in Small Cell Lung CancerEmory University · completed · Lung Cancer, Cancer of Lung, Pulmonary Cancer · principal investigator
- Ph2NCT01270321 · Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid CancerEmory University · completed · Thyroid Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancerR01CA273216 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Taofeek K Owonikoko · fiscal years 2022 to 2026Named on NCT05450965
- Novel systemic therapy to improve clinical outcome in small cell lung cancerK23CA164015 · NCI · EMORY UNIVERSITY · PI Taofeek K Owonikoko · fiscal years 2011 to 2015Named on NCT01470248
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.